Evidence map›Paper›PMID 33364385›Full record

ArticleLaryngoscope investigative otolaryngology2020

On the in vivo origin of human nasal mesenchymal stem cell cultures.

Rhea Choi, Stefania Goncalves, Michael A Durante, Bradley J Goldstein

Open access · goldAbstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Strategies to Develop Regenerative Medicine Approaches for Olfactory Disorders.Clinical and experimental otorhinolaryngology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. On the in vivo origin of human nasal mesenchymal stem cell cultures.Laryngoscope investigative otolaryngology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rhea ChoiMedical Scientist Training Program University of Miami Miller School of Medicine Miami Florida USA.ORCID https://orcid.org/0000-0002-3173-9890
Stefania GoncalvesDepartment of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA.ORCID https://orcid.org/0000-0003-3330-0918
Michael A DuranteMedical Scientist Training Program University of Miami Miller School of Medicine Miami Florida USA.ORCID https://orcid.org/0000-0003-3137-6847
Bradley J GoldsteinDepartment of Head and Neck Surgery & Communication Sciences Duke University School of Medicine Durham North Carolina USA.ORCID https://orcid.org/0000-0002-9612-1696
University of Miami · USDuke University · US

Funding

Therapeutic potential for modulation of olfactory basal stem cellsR01DC016859 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDSTEIN, BRADLEY J · 2018 to 2022
$2.2M
Nasal progenitor cells and olfactory neurogenesisK08DC013556 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDSTEIN, BRADLEY J · 2014 to 2018
$1.1M
NIDCD NIH HHS K08 DC013556NIDCD NIH HHS R01 DC016859
6 · The paper itself

Abstract

objectivesMesenchymal stem cells (MSCs), classically expanded in culture from bone marrow, are of broad interest to the regenerative medicine community. Human nasal turbinate mesenchymal-like stem cell cultures have also been described, defined by an in vitro phenotype similar to bone marrow MSCs. Nonetheless, the identity in vivo of the cells that give rise to nasal MSC-like cultures remains unclear, and these cells are often suggested to be related to olfactory lineages. Here, we sought to define the in vivo phenotype of human nasal MSC-like cells.

methodsHuman turbinate tissue samples were used for RNA and immunohistochemical analysis. We also analyzed a recently published single cell RNA-sequencing dataset from adult human olfactory and respiratory mucosa samples from our lab, to focus on cell populations expressing MSC markers. Immunochemistry was performed to stain turbinate sections and nasal MSC cultures for selected markers.

resultsWhile there is no single MSC-specific gene, we identified a human nasal mucosal cell population in vivo that uniquely expressed transcripts characteristic of typical MSC cultures, including ENG (CD105), NES, and CD34, and lacked expression of other transcripts associated with surface epithelia. The expression of transcription factors such as SOX17, EBF1, and FOXP1 suggests cells in the MSC-like cluster maintain an ability to direct cell fate, consistent with the behavior of nasal MSC-like cells in vitro. SOX17 was found to be uniformly expressed by nasal MSC cultures, consistent with the in vivo data. Immunohistochemistry of human nasal tissue samples indicated that ENG, CD34, and SOX17 expression localized selectively to cells surrounding blood vessels in the lamina propria.

conclusionOur findings provide evidence that the in vivo origin of nasal MSC-like cultures is likely a vascular or pericyte population, rather than cells related to the olfactory neuronal lineage. LEVEL OF EVIDENCE: NA.

Indexed as

mesenchymal stem cellsolfactory epitheliumrespiratory epitheliumsingle cell RNA sequencing

Identifiers

PMID33364385
PMCPMC7752059
OpenAlexW3092225190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.